Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
McKesson
Deloitte
Merck
Fuji
Federal Trade Commission
Express Scripts
Daiichi Sankyo
Teva

Generated: December 9, 2018

DrugPatentWatch Database Preview

Litigation Details for Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2011)

« Back to Dashboard

Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2011)

Docket ➤ Try a Free Trial Date Filed 2011-11-03
Court District Court, D. Delaware Date Terminated 2014-09-17
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties ACTAVIS INC.; ACTAVIS SOUTH ATLANTIC LLC; ACTAVIS, INC.; LTS LOHMANN THERAPIE-SYSTEME AG; NOVARTIS AG; NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.; NOVARTIS PHARMA AG; NOVARTIS PHARMACEUTICALS CORPORATION; PAR PHARMACEUTICAL INC.; WATSON LABORATORIES INC.; WATSON PHARMA INC.; WATSON PHARMACEUTICALS INC.
Patents 6,316,023; 6,335,031; 6,699,498
Attorneys Andrea M. Houston; C. Nicole Gifford; Daniel G. Brown; Daniel M. Silver; Dominick T. Gattuso; Erika R. Caesar; Erin A. Thomson; Gina R. Gencarelli; Jaclyn C. Levy; James L. Higgins; Jennifer Koh; Katharine Crawford Lester; Melanie K. Sharp; Michael P. Kelly; Michelle R. Ma; Robert M. Vrana; Stephen M. Hash; Steven J. Fineman
Firms Ballard Spahr LLP; Friedlander & Gorris, P.A.; Proctor Heyman LLP; Richards, Layton & Finger, PA; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc.
The small molecule drugs covered by the patents cited in this case are ➤ Try a Free Trial and ➤ Try a Free Trial .

Details for Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2011)

Date Filed Document No. Description Snippet Link To Document
2013-11-01 319 is not an oxidizing environment L`§.S poteet 6,699,498 (the “L'l`S petent’”‘), assigned to ]§*.§e…et limited States patents 6,3 35. l(“°OB] patent ) and 6 ,.3]6 {}23 (_ “’GZB patent ’) {_e~t)§leetivety…far below the threshold set by the LTS patent 'i`hc patents in colt also z‘ecognize that “co'l.npound…Composition” Ciaims {3 and 7 of the ’031 patent and 2 and 7 of the . ’{323 patent) I.~ ’}"here is No Evidenee…quot;’ C1aims (3 and 7 0'1" 1110 ’{)3 1 patent and 2 and 7 of the "023 paf‘enf) ........ External link to document
2014-06-18 40 detecting peroxides. U.S. Patent No. 6,699,498, 2:58- 62 ("the '498 patent") ("The peroxide…the '023 patent") (collectively, "the patents in suit"). Both patents share the same…that the patent examiner for the '023 and '031 patents considered both the '807 patent and U.S…alleging infringement of U.S. Patent Nos. 6,335,031 ("the '031 patent") and 6,316,023 ("…16, and 18 of the '031 patent and claims 2 and 7 of the '023 patent. Watson counters that the External link to document
2014-06-18 414 detecting peroxides. U.S. Patent No. 6,699,498, 2:58- 62 ("the '498 patent") ("The peroxide…the '023 patent") (collectively, "the patents in suit"). Both patents share the same…that the patent examiner for the '023 and '031 patents considered both the '807 patent and U.S…alleging infringement of U.S. Patent Nos. 6,335,031 ("the '031 patent") and 6,316,023 ("…16, and 18 of the '031 patent and claims 2 and 7 of the '023 patent. Watson counters that the External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cipla
Julphar
Moodys
Cantor Fitzgerald
McKinsey
Baxter
Queensland Health
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.